Intralesional Steroids in the Treatment of Alopecia Areata
A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata
Sponsor: Columbia University
Terminated
The PI left the Columbia University Medical Center. Study was not Completed.
Other terminated trials from Columbia University
Other Alopecia Areata trials with similar outcome
A PHASE4 clinical study on Alopecia Areata, this trial is terminated or withdrawn. The trial is conducted by Columbia University and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Terminated PHASE4
-
Jul 2019 — Nov 2019 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Apr 2019 — Jul 2019 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Sep 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .